Insider buying
~$26K15K sh @ $1.76
Traded Mar 6 · filed 4 days later
Callan Jmb's Chief Medical Officer paid $26K out of pocket for Callan Jmb shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Mar 20, 2026 · Filed Mar 26, 2026
Callan Jmb's Chief Medical Officer paid $18K out of pocket for Callan Jmb shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$17,841
Shares × reported transaction price
<$25K
+1.3%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 1 earlier confirmed purchase
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
11 days before results of Mar 31, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $1.95 on Mar 20, 2026, 76% above its 52-week low and 66% below its high, after a 13% rise over the previous 30 trading days
52-week range $1.11 (Dec 31, 2025) to $5.72 (Jul 22, 2025), 18% of the way up, from 251 adjusted closes. 30 trading days earlier: $1.72 on Feb 5, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Traded 11 days before CJMB reported its results (Mar 31, 2026)
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +2.3% | +3.9% | −1.6% |
| 30 days | −23.3% | +12.8% | −36.1% |
| 90 days | −39.8% | +15.8% | −55.6% |
| 180 days | +65.6% | +21.1% | +44.5% |
Past results only. Not a forecast.
Insider buying
Traded Mar 6 · filed 4 days later
Callan Jmb's Chief Medical Officer paid $26K out of pocket for Callan Jmb shares.
Insider filing
Traded Feb 4, 2025 · filed 336 days later
Compensation award — excluded from discretionary-purchase analysis.
Insider buying
Their first buy on recordTraded Dec 30, 2025 · filed 7 days later
A Callan Jmb director paid $562 out of pocket for Callan Jmb shares. 2 other people at Callan Jmb bought some too, in the same month.
David J Croyle, Chief Medical Officer's past purchases, 90 days after disclosure: 4 buys, median −44.2 pts vs S&P 500, beat it 0 of 4 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.